Roche Receives CE Mark for Blood Test to Identify Tuberculosis Infection
July 09, 2026
July 09, 2026
BASEL, Switzerland, July 9 -- Roche, a biotech company, issued the following news release:
* * *
Roche receives CE Mark for blood test to identify tuberculosis infection
* The Elecsys IGRA TB test expands global access to tuberculosis infection testing, advancing progress toward the World Health Organization's elimination targets.
* Performed on Roche's industry-leading and widely available cobas immunoassay systems, the test enables . . .
* * *
Roche receives CE Mark for blood test to identify tuberculosis infection
* The Elecsys IGRA TB test expands global access to tuberculosis infection testing, advancing progress toward the World Health Organization's elimination targets.
* Performed on Roche's industry-leading and widely available cobas immunoassay systems, the test enables . . .